← Back to headlines
Sagimet Biosciences Outlook Optimistic After Q4 and Full-Year 2025 Results
Analysts remain optimistic about Sagimet Biosciences (SGMT)'s future prospects following the release of its Q4 and full-year 2025 financial results.
25 Mar, 19:34 — 25 Mar, 19:34
Sources
Showing 1 of 1 sources
